Overview Financials News + Filings Key Docs Charts Ownership Insiders
All
All (ex-4s)
10-K
10-Q
8-K
3,4,5
Proxy
Prospectus
Other
Tags
Quarterly results
Inv. presentation
Acq. announced
CC transcript
|
|
MADRIGAL PHARMACEUTICALS, INC. (MDGL)
|
Create: Alert |
All | News | Filings
| Date Filed | Type | Description |
| 10/05/2023 |
SC 13D/A
| BAKER BROS. ADVISORS LP reports a 10% stake in Madrigal Pharmaceuticals, Inc. |
| 08/08/2023 |
SC 13D/A
| BAKER BROS. ADVISORS LP reports a 8.4% stake in Madrigal Pharmaceuticals, Inc. |
| 12/07/2021 |
SC 13D/A
| Form SC 13D/A - General statement of acquisition of beneficial ownership: [Amend] |
| 09/04/2020 |
SC 13D/A
| BAY CITY CAPITAL LLC reports a 18.6% stake in Madrigal Pharmaceuticals, Inc. |
| 06/01/2020 |
SC 13D/A
| BAY CITY CAPITAL LLC reports a 27.9% stake in Madrigal Pharmaceuticals, Inc. |
| 12/13/2019 |
SC 13D/A
| BAY CITY CAPITAL LLC reports a 27.1% stake in Madrigal Pharmaceuticals, Inc. |
| 10/17/2019 |
SC 13D/A
| Taub Rebecca reports a 8.2% stake in Madrigal Pharmaceuticals, Inc. |
| 10/17/2019 |
SC 13D/A
| FRIEDMAN PAUL A reports a 7.4% stake in Madrigal Pharmaceuticals, Inc. |
| 10/17/2019 |
SC 13D/A
| BAY CITY CAPITAL LLC reports a 34.8% stake in Madrigal Pharmaceuticals, Inc. |
| 08/01/2016 |
SC 13D/A
| CAXTON CORP reports a 4.6% stake in Madrigal Pharmaceuticals, Inc. |
| 07/26/2016 |
SC 13D/A
| CAXTON CORP reports a 5.5% stake in Madrigal Pharmaceuticals, Inc. |
| 04/15/2016 |
SC 13D/A
| CAXTON CORP reports a 15.8% stake in Synta Pharmaceuticals Corp. |
| 12/09/2015 |
SC 13D/A
| CAXTON CORP reports a 15.8% stake in Synta Pharmaceuticals Corp. |
| 12/07/2015 |
SC 13D/A
| CAXTON CORP reports a 16.8% stake in Synta Pharmaceuticals Corp. |
| 12/01/2015 |
SC 13D/A
| CAXTON CORP reports a 17.9% stake in Synta Pharmaceuticals Corp. |
| 11/20/2015 |
SC 13D/A
| CxSynta LLC reports a 21% stake in Synta Pharmaceuticals Corp. |
| 11/12/2015 |
SC 13D/A
| CxSynta LLC reports a 23% stake in Synta Pharmaceuticals Corp. |
| 10/29/2015 |
SC 13D/A
| CxSynta LLC reports a 27.2% stake in Synta Pharmaceuticals Corp. |
| 07/07/2015 |
SC 13D/A
| CxSynta LLC reports a 27.6% stake in Synta Pharmaceuticals Corp. |
| 04/10/2015 |
SC 13D/A
| CxSynta LLC reports a 27.6% stake in Synta Pharmaceuticals Corp. |
| 10/06/2014 |
SC 13D/A
| CxSynta LLC reports a 29% stake in Synta Pharmaceuticals Corp. |
| 04/23/2014 |
SC 13D/A
| CxSynta LLC reports a 32.7% stake in Synta Pharmaceuticals Corp. |
| 12/17/2013 |
SC 13D/A
| CxSynta LLC reports a 33.6% stake in Synta Pharmaceuticals Corp. |
| 12/16/2013 |
SC 13D/A
| CAXTON CORP reports a 33.6% stake in Synta Pharmaceuticals Corp. |
| 06/28/2013 |
SC 13D/A
| CxSynta LLC reports a 34.2% stake in Synta Pharmaceuticals Corp. |
| 06/06/2013 |
SC 13D/A
| CxSynta LLC reports a 32.6% stake in Synta Pharmaceuticals Corp. |
| 12/17/2012 |
SC 13D/A
| CxSynta LLC reports a 33.2% stake in Synta Pharmaceuticals Corp. |
| 11/16/2012 |
SC 13D/A
| CxSynta LLC reports a 29.5% stake in Synta Pharmaceuticals Corp. |
| 07/27/2012 |
SC 13D/A
| CxSynta LLC reports a 29.5% stake in Synta Pharmaceuticals Corp. |
| 07/03/2012 |
SC 13D/A
| CxSynta LLC reports a 25.4% stake in Synta Pharmaceuticals Corp. |
| 04/18/2011 |
SC 13D/A
| CxSynta LLC reports a 25.5% stake in Synta Pharmaceuticals Corp. |
| 11/12/2010 |
SC 13D/A
| CxSynta LLC reports a 26.5% stake in Synta Pharmaceuticals Corp. |
| 01/15/2010 |
SC 13D/A
| SYNTA PHARMACEUTICALS CORP reports a 4.9% stake in Synta Pharmaceuticals Corp. |
| 01/12/2010 |
SC 13D/A
| SYNTA PHARMACEUTICALS CORP reports a 23.6% stake in Synta Pharmaceuticals Corp. |
|
|